-
data. We have developed in vivo single-cell CRISPR technologies to screen for dozens of molecular factors in vivo during developmental and disease. These technologies are a game-changer in the speed
-
LMU Munich. The group is located within the Institute of Clinical Neuroimmunology (https://www.neuroimmunology-munich.de/ ). The professorship of Systems Neuroimmunology is part of the Cluster
Enter an email to receive alerts for crispr-"https:" positions